Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
Authors: Steven Tisseverasinghe, Marwan Tolba, Fred Saad, Gwenaëlle Gravis, Boris Bahoric, Tamim Niazi